{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:46:57Z","timestamp":1762505217809},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It has been suggested that cyclosporin A might be of some benefit to patients with Crohn's disease. The clinical response and side-effects of cyclosporin A in Crohn's disease are described in a series of 13 adults. The majority of patients had ileal disease and all but one were started on an initial oral dose of 15 mg\/kg per day. Duration of treatment ranged from 3 to 42 weeks. Of the 13 patients, 6 showed a response to therapy; the remainder showed no response or deteriorated. The commonest side-effect was hyperaesthesia, but one patient developed nephrotoxicity and one developed hepatotoxicity. Significant drug malabsorption occurred in one case. The side-effects were dose dependent and reversible. Cyclosporin A may have a part to play in the treatment of resistant Crohn's disease, and in our hands has been associated with a 46 per cent response rate; however, the precise role of cyclosporin A in the management of Crohn's disease awaits further study.<\/jats:p>","DOI":"10.1002\/bjs.1800751213","type":"journal-article","created":{"date-parts":[[2007,3,3]],"date-time":"2007-03-03T10:36:43Z","timestamp":1172918203000},"page":"1185-1188","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of Crohn's disease in relapse with cyclosporin A"],"prefix":"10.1093","volume":"75","author":[{"given":"N R","family":"Parrott","sequence":"first","affiliation":[{"name":"Department of Surgery, Royal Victoria Infirmary, University of Newcastle upon Tyne ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M R","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Victoria Infirmary, University of Newcastle upon Tyne ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C W","family":"Venables","sequence":"additional","affiliation":[{"name":"Department of Surgery, Royal Victoria Infirmary, University of Newcastle upon Tyne ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C O","family":"Record","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Victoria Infirmary, University of Newcastle upon Tyne ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1988,12,1]]},"reference":[{"key":"2024092719513886300_bib1","first-page":"5","volume-title":"Cyclosporin A","author":"Borel","year":"1981"},{"key":"2024092719513886300_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/gut.21.8.675","article-title":"Lymphocyte subpopulations of intestinal mucosa in inflammatory bowel disease","volume":"21","author":"Eade","year":"1980","journal-title":"Gut"},{"key":"2024092719513886300_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's disease activity","volume":"i","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"2024092719513886300_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(84)91358-8","article-title":"Cyclosporin for Crohn's disease","volume":"i","author":"Allison","year":"1984","journal-title":"Lancet"},{"key":"2024092719513886300_bib5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(84)91728-8","article-title":"Cyclosporin for Crohn's disease","volume":"i","author":"Bianchi","year":"1984","journal-title":"Lancet"},{"key":"2024092719513886300_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2036.1987.tb00604.x","article-title":"Cyclosporin for Crohn's disease","volume":"1","author":"Allison","year":"1987","journal-title":"Aliment Pharmacol Therap"},{"key":"2024092719513886300_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(84)92826-5","article-title":"Cyclosporin in ulcerative colitis","volume":"ii","author":"Gupta","year":"1984","journal-title":"Lancet"},{"key":"2024092719513886300_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"ii","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"2024092719513886300_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporin associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"New Eng J Med"},{"key":"2024092719513886300_bib10","first-page":"860","article-title":"Cyclosporin A: Preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants","volume":"11","author":"Calne","year":"1979","journal-title":"Transplant Proc."},{"key":"2024092719513886300_bib11","first-page":"2761","article-title":"Cyclosporin-associated hepatotoxicity after allogeneic bone marrow transplantation in man: differentiation from other causes of posttransplant liver disease","volume":"15","author":"Atkinson","year":"1983","journal-title":"Transplant Proc"},{"key":"2024092719513886300_bib12","first-page":"17","article-title":"The use of cyclosporin A and prednisone in cadaver kidney transplantation","volume":"151","author":"Starzl","year":"1980","journal-title":"Surg Gynecol Obstet"},{"key":"2024092719513886300_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0016-5085(79)90385-8","article-title":"National Cooperative Crohn's Disease Study: results of drug treatment","volume":"77","author":"Summers","year":"1979","journal-title":"Gastroenterology"}],"container-title":["Journal of British Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.1800751213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/75\/12\/1185\/59384846\/bjs1800751213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/75\/12\/1185\/59384846\/bjs1800751213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T19:53:00Z","timestamp":1727466780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/75\/12\/1185\/6183062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12,1]]},"references-count":13,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1988,12,1]]},"published-print":{"date-parts":[[1988,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.1800751213","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"type":"print","value":"0007-1323"},{"type":"electronic","value":"1365-2168"}],"subject":[],"published-other":{"date-parts":[[1988,12]]},"published":{"date-parts":[[1988,12,1]]}}}